Incretin-based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are
already established in the treatment of type 2 diabetes (T2D). The development of novel …

Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …

Introduction Various diagnostic tools are used to assess the severity of COVID-19 symptoms
and the risk of mortality, including laboratory tests and scoring indices such as the Modified …

The gut has been proposed as a potential alternative entry route for SARS-CoV-2. This was
mainly based on the high levels of SARS-CoV-2 receptor expressed in the gastrointestinal …

Natural herbs and functional foods contain bioactive molecules capable of augmenting the
immune system and mediating anti-viral functions. Functional foods, such as prebiotics …

Introduction Glycemic effects of COVID-19 lockdowns on patients with type 2 diabetes (T2D)
are controversial. In this long-term observation, we aimed (1) to analyze changes in HbA1c …

The COVID-19 pandemic has caused detrimental impacts on different population groups
throughout the world. This study aimed to explore the impacts of the COVID-19 pandemic's …

People with cardiometabolic diseases [namely type 2 diabetes (T2D), obesity, or metabolic
syndrome] are more susceptible to coronavirus disease 2019 (COVID-19) infection and …

Introduction Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), including administration of booster doses, continues to be the most effective method …

Objective Large body of studies described individuals with obesity experiencing a worse
prognosis in COVID-19. However, the effects of obesity on the prognosis of COVID-19 in …